Healthcare Services

Omics Lab Services Market Outlook 2026–2030: Key Business Drivers and Trends

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the omics lab services market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Omics Lab Services Market in 2026, and what figure is it projected to hit by 2030?

The omics lab services market has witnessed rapid expansion in recent years. Its size is expected to increase from $109.47 billion in 2025 to $126.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.7%. The historical growth of this market can be ascribed to several factors, including the expansion of life sciences research activities, the growth of pharmaceutical r&d pipelines, increasing availability of omics technologies, rising outsourcing of laboratory services, and the expansion of academic and clinical research collaborations.

The omics lab services market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $224.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.4%. This projected growth is driven by factors such as the increasing uptake of personalized medicine research, greater investments in systems biology, the proliferation of AI-enabled bioinformatics tools, a surging demand for comprehensive omics solutions, and a heightened emphasis on data-centric drug discovery. Key trends observed during this period encompass a rising need for integrated multi-omics analysis, the increasing utilization of contract research services, the broadened scope of bioinformatics-powered data interpretation, the escalating deployment of high-throughput analytical platforms, and an intensified commitment to supporting translational research.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28284&type=smp

Which Drivers Are Affecting Market Participation In The Omics Lab Services Market?

The increasing occurrence of genetic illnesses is projected to fuel the expansion of the omics lab services market moving ahead. Genetic diseases are conditions resulting from irregularities or changes in an individual’s DNA, which may be passed down genetically or manifest without prior inheritance. The incidence of genetic diseases is increasing because breakthroughs in diagnostic tools, especially next-generation sequencing and other genomic instruments, have substantially enhanced the capacity to discover and pinpoint numerous genetic disorders that were previously undetected or misidentified. Omics lab services assist in managing genetic diseases by analyzing intricate biological information to pinpoint mutations and molecular alterations, facilitating prompt diagnosis and tailored therapeutic approaches. As an illustration, figures from October 2024, provided by the Cystic Fibrosis Trust, a UK-based charity supporting cystic fibrosis patients, show that 11,148 cystic fibrosis patients were registered in 2022, a number that rose to 11,318 in 2023, indicating a 1.5% year-over-year increase in patient registrations. Consequently, the growing occurrence of genetic conditions is propelling the expansion of the omics lab services market.

What Segment Classifications Make Up The Omics Lab Services Market?

The omics lab services market covered in this report is segmented –

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics

2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions

3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools

4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications

5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization

2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics

3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics

4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting

5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

Which Competitive Trends Are Impacting The Structure Of The Omics Lab Services Market?

Leading companies within the omics lab services market are directing their efforts toward developing innovative solutions, such as high-throughput genomics, to accelerate biomedical research and advance precision medicine. High-throughput genomics utilizes advanced technologies to quickly sequence and analyze significant amounts of DNA or RNA, allowing for efficient large-scale genetic studies. As an example, in September 2024, The Translational Genomics Research Institute (TGen), a US-based nonprofit medical research institute, inaugurated the Center for Spatial Multi-Omics (COSMO). This center delivers high-resolution whole-transcriptome data using sequencing-based Visium HD alongside histological staining, and offers tissue processing services such as Tissue Microarray (TMA) construction for cost-effective, multiplexed sample analysis. Its customizable platforms, augmented by machine learning-driven cell segmentation, enable detailed visualization and mapping of molecular data within intact tissues, thereby supporting progress in precision medicine and disease research.

Which Major Industry Participants Are Leading The Omics Lab Services Market Growth?

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Omics Lab Services Market?

North America was the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics lab services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Omics Lab Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28284&type=smp

Browse Through More Reports Similar to the Global Omics Lab Services Market 2026, By The Business Research Company

Lab Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-supplies-global-market-report

Medical And Diagnostic Laboratory Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report

Medical And Diagnostic Laboratory Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795